Why is Solara Active falling/rising?

As of 31-Jul, Solara Active Pharma Sciences Ltd's stock price is currently at 638.70, reflecting a decrease of 14.3 points or 2.19%. Today's performance indicates that the stock opened with a loss of 2% and reached an intraday low of Rs 635, underperforming its sector by 0.7%. Over the past week, the stock has declined by 3.25%, and it has also shown a negative trend over the last month with a decrease of 2.39%. Despite positive fundamentals, such as a 16.9% growth in net sales and consistent profitability over the last four quarters, the stock's long-term performance has been hindered by a -7.45% CAGR growth in operating profits over the past five years and a high Debt to EBITDA ratio of 6.20 times, which raises concerns about its ability to service debt.
In the broader market context, the stock's short-term performance has been worse than the benchmark, with the Sensex declining by only 1.22% over the past week. Although Solara has outperformed the BSE500 in the long term, the recent drop in investor participation, with delivery volume falling by 51.78% against the five-day average, suggests a lack of confidence among investors. The company's attractive valuation and rising promoter confidence, with a 4.07% increase in stake, indicate potential for future growth; however, the current market sentiment appears to be overshadowed by concerns regarding its long-term fundamental strength.